Background
MicroRNAs (miRNAs) are small, non-coding RNA molecules that regulate gene expression by interacting with messenger RNAs (mRNAs). There is much hope that microRNA profiling can be a potentially valuable tool for improving the prognosis, diagnosis and treatment of disease (1), but there remains a significant gap in our knowledge about how exactly they function. In our laboratory, we are interested in how the regulation of specific miRNAs, and their gene networks, can contribute to disease progression. In particular we are interested in how miRNA expression contributes to the process of epithelial-mesenchymal transition (EMT)(2), which in turn is an important contributing factor to the progression of different diseases, including cancer (3) and glaucoma (4).
The current project will investigate the link between miRNAs and EMT by utilising a combination of in vitro, in vivo and in silico models, with a view to establishing the potential for disease management. This project brings together the research interests of the two listed supervisors, making it a strategic area of investigation for the Genomic Medicine Research Group.
Methods
The methods, equipment and expertise outlined below are routinely used in the laboratories of the supervisors. Papers featuring similar experimental approaches have been published by them (5-8).
Aims & objectives
Skills Required of Applicant
Applicants should hold, or expect to obtain, a First or Upper Second Class Honours Degree in a subject relevant to the proposed area of study.
We may also consider applications from those who hold equivalent qualifications, for example, a Lower Second Class Honours Degree plus a Master’s Degree with Distinction.
In exceptional circumstances, the University may consider a portfolio of evidence from applicants who have appropriate professional experience which is equivalent to the learning outcomes of an Honours degree in lieu of academic qualifications.
If the University receives a large number of applicants for the project, the following desirable criteria may be applied to shortlist applicants for interview.
The University offers the following levels of support:
The following scholarship options are available to applicants worldwide:
These scholarships will cover full-time PhD tuition fees for three years (subject to satisfactory academic performance) and will provide a £900 per annum research training support grant (RTSG) to help support the PhD researcher.
Applicants who already hold a doctoral degree or who have been registered on a programme of research leading to the award of a doctoral degree on a full-time basis for more than one year (or part-time equivalent) are NOT eligible to apply for an award.
Please note: you will automatically be entered into the competition for the Full Award, unless you state otherwise in your application.
The scholarship will cover tuition fees at the Home rate and a maintenance allowance of £19,000 (tbc) per annum for three years (subject to satisfactory academic performance).
This scholarship also comes with £900 per annum for three years as a research training support grant (RTSG) allocation to help support the PhD researcher.
Due consideration should be given to financing your studies. Further information on cost of living
References
1.Rupaimoole & Slack, Nat Rev Drug Discov. 2017 Mar;16(3):203-222.
2.Suzuki HI. Int J Mol Sci. 2018 Jun 28;19(7):1901.
3.Piletič & Kunej, Arch Toxicol. 2016 90(10):2405-19.
4.Liu et al, Curr Genomics. 2013 14(3):166-72
5.Lynch et al, Prostate, 2016 76(13):1146-5910.
6.Lynch et al, Prostate 2016 76(7):637-48.
7.Lechner et al, Invest Ophthalmol Vis Sci. 2013 54(8):5266-72.
8.Angel et al, J Cell Physiol. 2020 Sep;235(9):6194-6203.
Submission deadline
Friday 5 February 2021
12:00AM
Interview Date
Weeks commencing 15th and 22nd March 2021
Preferred student start date
Mid-September 2021
Telephone
Contact by phone
Email
Contact by email